Delivery Order SPE2DB22D1106-SPE2DB25FEUU1
Award Date
6/24/25
Potential Completion Date
6/25/25
Potential Value
$31K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,330.62 firm fixed-price contract is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a completion date of June 24, 2025. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,379.52, is for the delivery of ACTIVASE 50 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of June 23, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,439.07 firm fixed-price delivery order is for the supply of 4566293297 ACTIVASE 100 MG VIALS, with a completion date of November 1, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $83,574.45 firm fixed-price delivery order is for the supply of ACTIVASE 100 MG VIALS, a specialized medication, to support military healthcare programs. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. Amerisourcebergen holds a significant $999,999,999...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The order is for the supply of ACTIVASE 50 MG VIALS, a pharmaceutical product, with a potential value of $10,990.82 and a completion date of February 2, 2024. This delivery order is placed under Amerisourcebergen's indefinite delivery contract (IDC) with DLA, which has a potential...
This federal contract award is a delivery order valued at $12,326.19 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 50 MG VIALS medical products and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of ACTIVASE 100 MG VIALS. The $5,713.85 firm fixed price contract has an ultimate completion date of August 8, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies for the provision of a wide range of pharmaceutical products and medical supplies to support military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ACTIVASE 50 MG VIALS, a medical product, and has a firm fixed-price ceiling value of $9,014.34. The contract is non-set-aside, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $14,164.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of 100 mg vials of the pharmaceutical product ACTIVASE. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for the provision of a comprehensive range of medical commodities to support military treatment programs and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,997.33 firm fixed-price contract covers the delivery of ACTIVASE 50 MG VIALS, a critical medical commodity, with a period of performance through December 31, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a...